News

Pulse Biosciences is developing nsPFA technology for cardiac ablation to treat AFib and for ablating benign thyroid nodules.
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company") recently hosted Dr. Gary G. Tse, a ...
Despite promising technology and FDA clearances, Pulse Biosciences lacks a revenue stream and remains in the testing phase ...
Jimmy Wyman is running the Boston Marathon for his wife, who has a rare form of lung cancer, in support of Dana-Farber.
Black Mirror’s Eulogy episode trades dystopia for devastating emotion, delivering an unforgettable story about grief, love, ...
Learn more about whether Neurocrine Biosciences, Inc. or Veracyte, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Recently, we found, using a cigarette carcinogen-induced lung cancer model, that soy protein isolate (SPI) was superior to casein in preventing lung cancer. In this study, we have attempted to ...
The Ion Robotic Bronchoscopy System, a revolutionary tool in the field of pulmonary care, allows physicians to locate and ...
Pulmonologists share best practices on when primary care providers should consider sending patients with respiratory ...
Jean Hunsinger has no history of cancer in her family. Her mother, she said, lived to be 92. Her father reached the age of 89 ...
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company") recently announced a significant ...
Baird Medical (BDMD) announced a milestone in its international expansion. The FDA has issued a Certificate to Foreign Government to the ...